z-logo
open-access-imgOpen Access
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
Author(s) -
Yuchen Chen,
Dong Yang,
Biao Cheng,
Jian Chen,
Anlin Peng,
Chen Yang,
Chong Liu,
Mingrui Xiong,
Aiping Deng,
Yu Zhang,
Ling Zheng,
Kun Huang
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc20-0660
Subject(s) - medicine , diabetes mellitus , odds ratio , retrospective cohort study , type 2 diabetes , logistic regression , covid-19 , comorbidity , blood pressure , endocrinology , disease , infectious disease (medical specialty)
Diabetes is one of the most distinct comorbidities of COVID-19. Here, we describe the clinical characteristics of and outcomes in patients with diabetes in whom COVID-19 was confirmed or clinically diagnosed (with typical features on lung imaging and symptoms) and their association with glucose-lowering or blood pressure-lowering medications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom